Bridges Investment Counsel’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Bridges Investment Counsel's CELG Position: Q4 2017 in Review
Bridges Investment Counsel reduced its Celgene Corp (CELG) stake by 2.2% in Q4 2017, selling an estimated $60.4K and leaving 23,548 shares worth $2.46M. The position accounts for 1.36% of the portfolio, ranked #20.
Bridges Investment Counsel first reported a position in CELG in Q2 2013 and has held it in 19 quarters since. The position peaked at $13M in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.
- Bridges Investment Counsel held 23,548 shares of Celgene Corp worth $2.46M as of Q4 2017.
- Bridges Investment Counsel sold 535 Celgene Corp shares in Q4 2017, an estimated $60.4K.
- Celgene Corp made up 1.36% of Bridges Investment Counsel's portfolio in Q4 2017, its #20 holding.
- Bridges Investment Counsel first reported a position in Celgene Corp in Q2 2013 and has held it in 19 quarters since.
- Bridges Investment Counsel's Celgene Corp position peaked at $13M in Q4 2015.
- 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.
Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.